The Australian sharemarket climbed, extending its financial year gain as progress in US trade negotiations boosted investor sentiment.
The S&P/ASX 200 Index rose 28.1 points, or 0.3 per cent, to 8542.3 Monday, with seven out of the 11 sectors gaining. Health and technology led the advance.
Investors tracked a rally on Wall Street that pushed the S&P 500 to a fresh record of 6170 on Friday and Nvidia towards $US4 trillion ($6.1 trillion) in market capitalisation. Oil and gold were lower amid the increased risk-on environment.
US President Donald Trump told the media over the weekend that he did not think he needed to extend the July 9 tariff deadline for countries negotiating with the US.
Among the countries in talks, India is reported to have extended its stay in Washington to iron out a deal, Canada has withdrawn its digital services tax on technology companies to restart negotiations, and Taiwan has said it made “constructive progress”.
On the ASX, investors have piled into health stocks, with CSL up 2.2 per cent to $239.48, Pro Medicus up 1.6 per cent to $285.08, and Sigma Healthcare up 1.4 per cent to $2.99, and Cochlear gained 1.7 per cent to $300.42.
The tech sector was also well bid with NextDC up 2.2 per cent to $14.50 and financials edged higher. While Commonwealth Bank dipped 0.3 per cent to $184.75, National Australia Bank edged up 0.3 per cent to $39.36, and Macquarie Group climbed 3.9 per cent to $228.73.
Investors took profits from the big iron ore producers on the last day of the financial year, with Rio Tinto down 1.7 per cent to $107.13, Fortescue down 1.2 per cent to $15.28, and BHP falling 2.1 per cent to $36.75.
In corporate news, James Hardie rose 7.1 per cent to $41.70 after shareholders in US outdoor decking company Azek approved a $14 billion buyout, which will see James Hardie shift its primary listing to New York.
Star Entertainment tanked 6.9 per cent 14¢ after its Hong Kong investors threatened to walk away from a deal for Brisbane’s new Queen’s Wharf casino and hotel complex.
DroneShield fell 4.2 per cent to $2.28 after earlier rallying on news it had won a $9.7 million Latin American defence contract. That’s after last week’s 33 per cent rally from announcing a major European deal.
NIB jumped 9.4 per cent to $7.08 after UBS upgraded the private health insurer to “buy” from “neutral” and set a short-term share price target of $7.85, which implies an upside of more than 20 per cent.
And Superloop rose 1 per cent to $3.01 after the broadband provider said it expected underlying earnings to reach $91 million for the full year, beating its earlier guidance of $83 million to $88 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.